MA
MASS.US 908 Devices Inc
- Market cap
- USD 405M
- P/E
- -
- P/B
- 2.70x
- ROE
- -25.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is MASS.US undervalued?
Graham numberThe Graham number of 908 Devices Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
908 Devices Inc fundamental analysis
No fundamental analysis for 908 Devices Inc yet.
908 Devices Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About 908 Devices Inc
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portabl…
Full company profile908 Devices Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
908 Devices Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 22.1M | 18.0M | 26.9M | 42.2M | 46.9M | 50.2M | 59.6M | 56.2M | 64.5M |
| Gross Profit | 12.4M | 8.14M | 14.9M | 23.2M | 26.0M | 25.3M | 29.9M | 26.8M | 33.0M |
| Operating Income | -6.44M | -12.1M | -5.82M | -22.1M | -35.4M | -42.8M | -76.7M | -24.2M | -33.5M |
| EBITDA | -5.49M | -11.2M | -4.98M | -20.8M | -33.8M | -40.3M | -43.9M | -28.9M | -34.7M |
| Net Income | -7.54M | -13.4M | -12.8M | -22.2M | -31.7M | -36.4M | -72.2M | -36.6M | -37.9M |
| EPS | -0.93 | -1.78 | -2.34 | -0.79 | -1.01 | -1.13 | -2.12 | -0.94 | -0.92 |
| Balance Sheet | |||||||||
| Total Assets | 27.7M | 37.7M | 179M | 261M | 243M | 203M | 159M | 190M | 199M |
| Total Liabilities | 77.9M | 101M | 39.8M | 46.3M | 52.0M | 37.5M | 44.9M | 46.4M | 49.6M |
| Shareholders' Equity | -50.2M | -63.2M | 139M | 215M | 191M | 165M | 115M | 144M | 150M |
| Cash & Short-term Investments | 7.07M | 17.9M | 159M | 224M | 188M | 146M | 69.6M | 113M | 99.1M |
| Total Debt | 17.9M | 22.8M | 21.9M | 20.9M | 19.5M | 5.95M | 6.61M | 16.7M | 5.05M |
| Cash Flow | |||||||||
| Operating Cash Flow | -8.90M | -11.0M | 4.13M | -29.1M | -20.9M | -25.1M | -30.2M | -23.7M | 1.93M |
| Capital Expenditure | 727K | 392K | 9.00K | 737K | 2.05M | 2.05M | 602K | 955K | 356K |
| Free Cash Flow | -9.63M | -11.4M | 4.12M | -29.8M | -23.0M | -27.1M | -30.8M | -24.6M | 1.57M |
| Ratios | |||||||||
| ROE | - | - | -9.2% | -10.3% | -16.7% | -22.0% | -63.0% | -25.5% | -25.3% |
| ROA | -27.2% | -35.5% | -7.2% | -8.5% | -13.1% | -17.9% | -45.3% | -19.3% | -19.0% |
| Net Profit Margin | -34.2% | -74.4% | -47.7% | -52.5% | -67.8% | -72.5% | -121.1% | -65.2% | -58.7% |
| Debt to Equity | - | - | 0.16x | 0.10x | 0.10x | 0.04x | 0.06x | 0.12x | 0.03x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
908 Devices Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | USD 262K | 0.01 | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns 908 Devices Inc
- Insiders 7.41%
- Institutions 89.77%
- Public & others 2.82%
- Shares outstanding 41.6M
- Free float 28.0M
Top funds holding MASS.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| ARK Genomic Revolution ETF | 2.05M | 4.95% | +0.58% | Oct 2026 |
| Needham Aggressive Growth Retail | 1.54M | 3.72% | +10.19% | Sep 2026 |
| Avantis US Small Cap Value ETF | 1.10M | 2.66% | +1.58% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 920K | 2.22% | 0.00% | Sep 2026 |
| iShares Russell 2000 ETF | 786K | 1.90% | 0.00% | Oct 2026 |
| First Eagle Small Cap Opportunity I | 770K | 1.86% | -9.82% | Sep 2026 |
| Fidelity Small Cap Index | 317K | 0.77% | 0.00% | Aug 2026 |
| iShares Russell 2000 Value ETF | 292K | 0.70% | 0.00% | Oct 2026 |
| Needham Small Cap Growth Retail | 245K | 0.59% | -3.15% | Sep 2026 |
| Vanguard Russell 2000 ETF | 184K | 0.44% | +10.21% | Sep 2026 |
| Schwab US Small-Cap ETF™ | 175K | 0.42% | +0.24% | Oct 2026 |
| Victory Small Cap Stock | 156K | 0.38% | +0.83% | Sep 2026 |
| Lord Abbett Micro Cap Growth I | 155K | 0.37% | +23.31% | Sep 2026 |
| Fidelity Extended Market Index | 151K | 0.36% | +8.18% | Sep 2026 |
| ARK Genomic Revolution ETF A USD Acc | 131K | 0.32% | 0.00% | Oct 2026 |
| 1290 Essex Small Cap Growth I | 114K | 0.28% | +0.53% | Sep 2026 |
| Acuitas US Microcap Institutional | 101K | 0.24% | -22.26% | Jun 2026 |
| Avantis® U.S. Small Cap Value Instl | 99.1K | 0.24% | +43.95% | Sep 2026 |
| iShares Micro-Cap ETF | 95.7K | 0.23% | 0.00% | Oct 2026 |
| Stt Strt® SPDR® S&PKenshoFutSecETF | 89.1K | 0.22% | 0.00% | Oct 2026 |
Top institutions holding MASS.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| First Light Asset Management, LLC | 6.28M | 15.17% | +3.46% | Jun 2026 |
| Awm Investment Company Inc | 4.88M | 11.78% | -6.16% | Jun 2026 |
| ARK Investment Management LLC | 2.03M | 4.90% | +4.17% | Jun 2026 |
| BlackRock Inc | 1.94M | 4.69% | +10.01% | Jun 2026 |
| Arnhold & S. Bleichroeder Advisers, LLC | 1.86M | 4.49% | +131.45% | Jun 2026 |
| Needham Investment Management, LLC | 1.82M | 4.40% | +46.82% | Jun 2026 |
| Vanguard Capital Management, LLC | 1.29M | 3.12% | +15.40% | Jun 2026 |
| American Century Companies Inc | 1.17M | 2.83% | +225.59% | Sep 2026 |
| Geode Capital Management, LLC | 762K | 1.84% | +9.54% | Jun 2026 |
| Granahan Investment Management Inc.. | 692K | 1.67% | -0.43% | Jun 2026 |
| State Street Corp | 607K | 1.46% | -3.09% | Jun 2026 |
| Essex Investment Management Company, LLC | 470K | 1.14% | -4.27% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 404K | 0.98% | +8.26% | Jun 2026 |
| Prescott Group Capital Management LLC | 362K | 0.87% | 0.00% | Jun 2026 |
| Meros Investment Management, LP | 361K | 0.87% | -0.10% | Jun 2026 |
| Renaissance Technologies Corp | 313K | 0.76% | +62.95% | Sep 2026 |
| Northern Trust Corp | 266K | 0.64% | +10.39% | Jun 2026 |
| Bank of America Corp | 251K | 0.61% | +900.98% | Jun 2026 |
| Charles Schwab Investment Management Inc | 234K | 0.56% | +1.92% | Jun 2026 |
| Amova Asset Management Americas, Inc | 229K | 0.55% | -15.26% | Jun 2026 |
908 Devices Inc company profile
- Company name
- 908 Devices Inc
- Ticker
- MASS.US
- Exchange
- USA Stocks
- Listed since
- Dec 18, 2020
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 172
- Fiscal year end
- December
- Address
- 44 3rd Avenue, Burlington, MA, United States, 01803
- Phone
- 857 254 1500
- Website
- 908devices.com
About 908 Devices Inc
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
908 Devices Inc management
6- Dr. Kevin J. Knopp Ph.D.Co-Founder, CEO, President & Director · born 1973
- Dr. Christopher David Brown Ph.D.Co-Founder, Board Advisor & Director · born 1975
- Mr. Joseph H. Griffith IVCFO & Treasurer · born 1975
- Mr. Mark S. Levine J.D.Chief Legal, Administrative Officer & Corporate Secretary · born 1973
- Mr. John KennewegSenior Vice President of Sales and Product Marketing · born 1973
- Ms. Julie CincottiGlobal Head of Human Resources